Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India

AIDS Research and Human Retroviruses

Volumn 30, Issue 3, 2014, Pages 294-298

  Kumar, Mukesh ^a   Sen, Sourav ^b   Gupta, Rakesh K ^c   Chaturbhuj, Devidas ^d   Tripathy, Srikanth P ^e   Paranjape, Ramesh S ^d  

^a Government Medical College   (India)

^b ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^c Department of Laboratory Medicine and Transfusion Medicine   (India)

^d NATIONAL AIDS RESEARCH INSTITUTE   (India)

^e INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ADOLESCENT; AMPLICON; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; T LYMPHOCYTE; VIRUS MUTATION; VIRUS RESISTANCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 84895509400     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0222     Document Type: Article

References (20)

1. Becquet R, Ekouevi DK, Arrive E, Stringer JS, Meda N, Chaix ML, et al.: Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis 2009;49(12):1936-1945.
2. UNAIDS/WHO: Paediatric HIV surveillance among infants and children less than 18 years of age. World Health Organization 2013. Available at http://apps.who.int/iris/bitstream/10665/85513/1/9789241505833-eng.pdf. Accessed on August 22, 2013.
3. Deshpande A, Recordon P, Deshmukh R, Faure M, Jauvin V, Garrigue I, et al.: Molecular characterization of HIV type 1 isolates from unrelated patients of Mumbai (Bombay) India: A detection of rare resistance mutations. AIDS Res Hum Retroviruses 2004;20:1032-1035.
4. Balakrishnan P, Kumaraswamy N, Kantor R, Solomon S, Vidya S, Mayer KH, et al.: HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. AIDS Res Hum Retroviruses 2005;21(4):301-305.
5. Sen S, Tripathy SP, Chimanpure VM, Patil AA, Bagul RD, and Paranjape RS: Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment naïve and treatment experienced patients from Pune, India. AIDS Res Hum Retroviruses 2007;23(4):489-497.
6. Sen S, Tripathy SP, Patil AA, Chimanpure VM, and Paranjape RS: High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment experienced patients from Pune, India. AIDS Res Hum Retroviruses 2007;23(10):1303-1308.
7. Lall M, Gupta RM, Sen S, Kapila K, Tripathi SP, and Paranjape RS: Profile of primary resistance in HIV-1 infected treatment naïve individuals from Western India. AIDS Res Hum Retroviruses 2008;24(7):987-990.
8. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, and Kumar S: MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28: 2731-2739.
9. Ferreira FG, Pinto JA, Kakehasi FM, Cleto S, Tupinambás U, Aleixo AW, et al.: Prevalence of primary drug resistance-associated mutations among HIV Type 1 vertically infected children in Belo Horizonte, Brazil. AIDS Res Hum Retroviruses 2010;26(2):229-232.
10. Cane P, Chrystie I, Dunn D, Evans B, Geretti AM, Green H, et al.: Time trends in primary resistance to HIV drugs in the United Kingdom: Multicentre observational study. BMJ 2005;331:7529.
11. Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, et al.: Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. J Infect Dis 2005;192(6):958-966.
12. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf. Accessed on August 16, 2013.
13. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/ pediatric guidelines.pdf. Accessed on August 16, 2013.
14. Persaud D, Palumbo P, Ziemniak V, Chen J, Ray SC, Hughes M, et al.: Early archiving and predominance of non nucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis 2007;195(10):1402-1410.
15. Chakraborty R, Smith CJ, Dunn D, Green H, Duong T, Doerholt K, et al.: HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004. Pediatr Infect Dis J 2008;27(5):457-459.
16. Pedroso C, Queiroz ATL, Alcantara LC, Drexler JF, Diaz RS, Weyll N, et al.: High prevalence of primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a northeast state of Brazil. J Acquir Immune Defic Syndr 2007;45(2):251-253.
17. Soto-Ramirez LE, Rodriguez-Diaz R, Harris DR, and Hazra R: HIV drug resistance-associated mutations in antiretroviral naïve HIV-1-infected Latin American children. Adv Virol 2010;2010:407476.
18. Kurle S, Gangakhedkar RR, Sen S, Hayatnagarkar SS, Tripathy SP, and Paranjape RS: Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV Type 1 subtype C-infected infants in India. AIDS Res Hum Retroviruses 2007:23(5):682-685.
19. Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, et al.: Nevirapine resistance and breast-milk HIV transmission: Effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One 2009;4(1):e4096.
20. Soundararajan L, Karunaianandham R, Jauvin V, Schrive MH, Ramachandran R, Narayanan PR, et al.: Characterization of HIV-1 isolates from antiretroviral drug-naïve children in southern India. AIDS Res Hum Retroviruses 2007;23(9):1119-1126.